The potential benefit of 6 vs. 3 cycles of chemotherapy in subsets of women with early-stage high-risk epithelial ovarian cancer: an exploratory analysis of a Gynecologic Oncology Group study (Q45237716)
Jump to navigation
Jump to search
scientific article published on 28 November 2009
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | The potential benefit of 6 vs. 3 cycles of chemotherapy in subsets of women with early-stage high-risk epithelial ovarian cancer: an exploratory analysis of a Gynecologic Oncology Group study |
scientific article published on 28 November 2009 |
Statements
1 reference
The potential benefit of 6 vs. 3 cycles of chemotherapy in subsets of women with early-stage high-risk epithelial ovarian cancer: an exploratory analysis of a Gynecologic Oncology Group study (English)
1 reference
Bradley J Monk
1 reference
John K Chan
1 reference
Chunqiao Tian
1 reference
Gini F Fleming
1 reference
Thomas J Herzog
1 reference
Daniel S Kapp
1 reference
Jeffrey Bell
1 reference
28 November 2009
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference